Test Price
550 AED✅ Home Collection Available
Bone Marrow Karyotyping Analysis in UAE | 550 AED | DHA Licensed
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity — ISO 15189 Plus Accredited Processing with conventional G-banding and 20-metaphase analysis.
- Hospital Extraction Only — Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance — Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed consultant.
- Insurance — Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Bone marrow karyotyping provides a complete chromosomal map from cultured bone marrow cells to detect numerical and structural abnormalities crucial for diagnosing leukemia, myelodysplasia, and constitutional genetic syndromes.
| Feature | Our Bone Marrow Karyotyping | Peripheral Blood Karyotype |
|---|---|---|
| Methodology | Conventional Karyotyping with G-banding, 20 metaphases | Conventional Karyotyping with G-banding (requires hematopoietic stimulation) |
| Target Tissue | Bone marrow aspirate (direct assessment of myeloid lineage) | Peripheral blood (lymphocytes), not ideal for myeloid disorders |
| Clinical Utility | Gold standard for AML, MDS, CML, MPN, and recurrent pregnancy loss workup | Mainly for constitutional disorders, secondary amenorrhea, or recurrent miscarriages |
| Turnaround Time | 7–8 days | 10–14 days |
| Price | 550 AED | ~650 AED |
Physician Insight & Safety Protocols
“Bone marrow karyotyping is a vital diagnostic tool for detecting chromosomal abnormalities that guide treatment decisions in hematological malignancies. I encourage patients to thoroughly review results with their treating hematologist to understand the implications for therapy.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Reg. ID: 9294403
Clinical Advisory
⚠️ Do not discontinue prescribed medication without consulting your doctor. Always inform your physician about all medications and supplements before undergoing bone marrow aspiration.
Safety & Exclusion Criteria
- Bleeding Diathesis: Uncorrected coagulopathy, low platelets <50,000/µL, or use of anticoagulants without medical clearance.
- Local Infection: Cellulitis or abscess at the planned aspiration site (usually posterior iliac crest).
- Unstable Patient: Severe hemodynamic instability or inability to lie still for the procedure.
- Pregnancy: Bone marrow aspiration is avoided unless absolutely necessary and cleared by the obstetrician.
🚨 Seek immediate medical attention if you experience:
- Fever >38.5°C or chills within 48 hours
- Excessive bleeding, expanding hematoma, or severe pain unrelieved by prescribed analgesics
- Signs of infection: redness, pus, or warmth at the puncture site
Patient FAQ & Clinical Guidance
1. Why is bone marrow karyotyping preferred over peripheral blood for leukemia diagnosis?
Bone marrow directly reveals chromosomal abnormalities in myeloid precursors that peripheral blood often misses. This test cultures the actual malignant clone, providing higher detection of clonal aberrations critical in acute myeloid leukemia and myelodysplastic syndromes. Peripheral blood may only capture lymphoid cells, missing key myeloid markers.
2. How should I prepare for a bone marrow aspiration for karyotyping?
Stop blood thinners 5 days prior after consulting your physician, fast for 6 hours, and arrange for someone to drive you home post-procedure. A valid DHA-licensed physician’s prescription is mandatory. Wear comfortable clothing and avoid driving if sedation is used.
3. Can bone marrow karyotyping detect all genetic disorders?
Karyotyping detects large chromosomal changes like aneuploidy and balanced translocations but may miss small deletions or point mutations. For submicroscopic imbalances, additional tests such as chromosomal microarray or next-generation sequencing may be recommended.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is handled with the highest confidentiality and security measures.
Our DHA Facility License No. 1143 ensures compliance with Dubai Healthcare City Authority and UAE federal health regulations. For more details on our privacy practices, please contact our Data Protection Officer.
Clinical & Logistical Metadata
| Test Name | Bone Marrow Karyotyping Analysis |
| Price (AED) | 550 AED |
| Turnaround Time | 7–8 days |
| Sample Type / Matrix | Bone marrow aspirate (Hospital Extraction Only) |
| Methodology Used | Conventional Karyotyping with G-banding, 20 metaphases |
| ICD-10-CM Code | Z01.89 |
| LOINC Code | 623-7 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians